SCHEMBL24164417

SCHEMBL24164417

CC(C)Nc1ccc(C(=O)N(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ RXFP1 Q9HBX9 2/20 0.47
▸ HTT P42858 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.43
▸ CSNK2A1 P68400 1/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ NR1H4 Q96RI1 1/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ACACB O00763 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25905782 0.85 RXFP1 (0.45) ALDH1A1HPGDRXFP1HTTTDP1
SCHEMBL194039 0.79 RXFP1 (0.53) SMN1; SMN2ALDH1A1HPGDRXFP1HTT
SCHEMBL1004649 0.78 ALDH1A1 (0.73) SMN1; SMN2ALDH1A1HPGDHTTTDP1
SCHEMBL19459308 0.78 ALDH1A1 (0.55) SMN1; SMN2ALDH1A1HPGDRXFP1HTT
SCHEMBL5013530 0.78 ALDH1A1 (0.55) SMN1; SMN2ALDH1A1HPGDRXFP1HTT
SCHEMBL10055051 0.78 RXFP1 (0.56) SMN1; SMN2ALDH1A1HPGDRXFP1HTT
SCHEMBL1663456 0.78 HCAR3 (0.55) SMN1; SMN2ALDH1A1HPGDRXFP1TDP1
SCHEMBL6842263 0.77 ALDH1A1 (0.66) SMN1; SMN2ALDH1A1HPGDRXFP1HTT
SCHEMBL1782141 0.76 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDRXFP1HTT
SCHEMBL10024338 0.76 RXFP1 (0.50) SMN1; SMN2ALDH1A1HPGDRXFP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006439-A2 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-01-06 — — WO disclosed
Send feedback